SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-16-006478
Filing Date
2016-08-08
Accepted
2016-08-08 16:06:13
Documents
2
Period of Report
2016-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CLOVIS ONCOLOGY, INC. 8-K a51398105.htm 8-K 17531
2 EXHIBIT 99.1 a51398105ex99_1.htm EX-99.1 87194
  Complete submission text file 0001157523-16-006478.txt   105862
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35347 | Film No.: 161814181
SIC: 2834 Pharmaceutical Preparations